AdvaMed and ABHI renewed their MOU to enhance collaboration on AI regulation, trade policy, and regulatory convergence, aiming to improve patient access to advanced medical technologies in the U.S. and U.K. medtech markets.
AdvaMed announces that Lester B. Knight, a founding partner of RoundTable Healthcare Partners and former chief executive of Allegiance, will receive the 2022 AdvaMed Lifetime Achievement Award at the industry’s annual gathering, The MedTech Conference 2022, in Boston on October 26.
AdvaMed has requested that the U.S. Department of Health & Human Services extend the declared federal public health emergency beyond its current expiration date, so that the medical technology industry can continue to efficiently deliver the tools hospitals need to treat people with COVID-19.
AdvaMed and ABHI renewed their MOU to enhance collaboration on AI regulation, trade policy, and regulatory convergence, aiming to improve patient access to advanced medical technologies in the U.S. and U.K. medtech markets.
FDA Commissioner Stephen Hahn, MD, joined a special meeting of AdvaMed’s Board of Directors today to discuss how the medical technology industry and FDA can continue their work together to ensure patients and health care providers have the medical equipment they need to address the COVID-19 pandemic.
Read More
The Advanced Medical Technology Association (AdvaMed) announces that its board of directors has approved an update of its longstanding Code of Ethics on Interactions with Health Care Professionals in the United States. The revisions will be effective Jan. 1, 2020, to ensure ample time for stakeholder implementation.
Read More
By becoming one of more than 300 members of AdvaMed, GE Healthcare will join other industry leaders to ensure medical technology innovations can be accessed by hospitals and health systems to deliver precision medicine to patients around the globe.
Read More